Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study
Author:
Funder
Grantová Agentura, Univerzita Karlova
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology, and Child Health
Link
http://link.springer.com/article/10.1007/s00431-018-3255-2/fulltext.html
Reference24 articles.
1. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035. https://doi.org/10.1038/sj.ki.5002231
2. Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2014) Laboratory predictors of acute dialysis in hemolytic uremic syndrome. Pediatr Int 56:234–239. https://doi.org/10.1111/ped.12245
3. Balestracci A, Meni Battaglia L, Toledo I, Martin SM, Alvarado C (2018) Blood urea nitrogen to serum creatinine ratio as a prognostic factor in diarrhea-associated hemolytic uremic syndrome: a validation study. Eur J Pediatr 177:63–68. https://doi.org/10.1007/s00431-017-2999-4
4. Bruyand M, Mariani-Kurkdjian P, Gouali M, de Valk H, King LA, le Hello S, Bonacorsi S, Loirat C (2018) Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection. Med Mal Infect 48:167–174. https://doi.org/10.1016/j.medmal.2017.09.012
5. Ehrlenbach S, Rosales A, Posch W, Wilflingseder D, Hermann M, Brockmeyer J, Karch H, Satchell SC, Würzner R, Orth-Höller D (2013) Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells. Infect Immun 81:2678–2685. https://doi.org/10.1128/IAI.01079-12
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eculizumab in Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: a systematic review;Pediatric Nephrology;2023-12-06
2. Haemolytic Uremic Syndrome: A Study Cohort over 10-Year Period in a Paediatric Tertiary Centre Hospital;Nephron;2022-12-21
3. HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl;Pediatric Nephrology;2022-08-15
4. Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis;JCI Insight;2022-03-22
5. Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic Escherichia coli;Current Neuropharmacology;2020-12-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3